|
Eine Ebene nach oben |
Gruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 5
2022
Miesbach, Wolfgang; Oldenburg, Johannes; Klamroth, Robert; Eichler, Hermann; Koscielny, Jürgen; Holzhauer, Susanne; Holstein, Katharina; Hovinga, Johanna A. Kremer; Alberio, Lorenzo; Olivieri, Martin; Knöfler, Ralf; Male, Christoph und Tiede, Andreas
(2022):
Gene therapy of Haemophilia: Recommendations from the German, Austrian, and Swiss Society for Thrombosis and Haemostasis Research (GTH).
In: Hämostaseologie, Bd. 43, Nr. 3: S. 196-207
Miesbach, Wolfgang; Eichler, Hermann; Holstein, Katharina; Holzhauer, Susanne; Klamroth, Robert; Knofler, Ralf; Male, Christoph; Olivieri, Martin; Oldenburg, Johannes und Tiede, Andreas
(2022):
Electronic diaries in the management of haemophilia gene therapy: Perspective of an expert group from the German, Austrian and Swiss Society on Thrombosis and Haemostasis (GTH).
In: Haemophilia, Bd. 28, Nr. 2: S. 264-269
2021
Male, Christoph; Andersson, Nadine G.; Rafowicz, Anne; Liesner, R. I.; Kurnik, Karin; Fischer, Kathelijn; Platokouki, Helen; Santagostino, Elena; Chambost, Herve; Nolan, Beatrice; Koeigs, Christoph; Kenet, Gili; Ljung, Rolf und Berg, H. Marijke van den
(2021):
Inhibitor incidence in an unselected cohort of previously untreated patients with severe hemophilia B: a PedNet study.
In: Haematologica, Bd. 106, Nr. 1: S. 123-129
2020
Holstein, Katharina; Albisetti, Manuela; Bidlingmaier, Christoph; Halimeh, Susan; Heine, Sabine; Klamroth, Robert; Königs, Christoph; Kurnik, Karin; Male, Christoph; Oldenburg, Johannes; Streif, Werner; Wermes, Cornelia und Escuriola-Ettingshausen, Carmen
(2020):
Practical Guidance of the GTH Haemophilia Board on the Use of Emicizumab in Patients with Haemophilia A.
In: Hamostaseologie, Bd. 40, Nr. 05: S. 561-571
2019
van den Berg, H. Marijke; Fischer, Kathelijn; Carcao, Manuel; Chambost, Herve; Kenet, Gili; Kurnik, Karin; Konigs, Chris; Male, Christoph; Santagostino, Elena und Ljung, Rolf
(2019):
Timing of inhibitor development in more than 1000 previously untreated patients with severe hemophilia A.
In: Blood, Bd. 134, Nr. 3: S. 317-320